Literature DB >> 18240291

Id1 delays senescence of primary human melanocytes.

Staci D Cummings1, Byungwoo Ryu, Michael A Samuels, Xiaobing Yu, Alan K Meeker, Megan A Healey, Rhoda M Alani.   

Abstract

The Id family of helix-loop-helix transcription factors is upregulated in a variety of human malignancies and has been implicated in promoting tumorigenesis through effects on cell growth, differentiation, and tumor angiogenesis. While expression of Id proteins has been associated with tumorigenesis, the precise mechanistic relationship between Id expression and carcinogenesis has not been clearly delineated. We have previously shown that Id1 delays cellular senescence in primary mammalian cells through inhibition of the cell cycle regulatory protein and familial melanoma gene, p16/INK4a. We have also demonstrated that Id1 expression is upregulated in early stage primary human melanomas and may be an important marker for early malignancy. In order to further define the role of Id1 in human melanoma development, we have evaluated the function of Id1 in primary human melanocytes. Here we show that constitutive expression of Id1 in primary human melanocytes leads to delayed cellular senescence and decreased expression of the familial melanoma gene, p16/INK4a. Although melanocytes constitutively expressing Id1 are shown to possess extended lifespans, this is not associated with an appreciable change in cell growth or telomere length. We conclude that Id1 delays cellular senescence in primary human melanocytes through inhibition of p16/INK4a expression and suggest that Id1 may contribute to the malignant conversion of primary human melanocytes through extension of cellular lifespan.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18240291      PMCID: PMC4066980          DOI: 10.1002/mc.20422

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  25 in total

Review 1.  Role of Id family proteins in growth control.

Authors:  Yoshifumi Yokota; Seiichi Mori
Journal:  J Cell Physiol       Date:  2002-01       Impact factor: 6.384

2.  Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells.

Authors:  Xiaobing Yu; Xiangcan Zhan; Jenice D'Costa; Vivek M Tanavde; Zhaohui Ye; Tien Peng; Matthew T Malehorn; Xiaoming Yang; Curt I Civin; Linzhao Cheng
Journal:  Mol Ther       Date:  2003-06       Impact factor: 11.454

Review 3.  Id proteins in cell growth and tumorigenesis.

Authors:  Hashmat A Sikder; Meghann K Devlin; Shariff Dunlap; Byungwoo Ryu; Rhoda M Alani
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

4.  High-efficiency stable gene transduction in primary human melanocytes using a lentiviral expression system.

Authors:  Shariff Dunlap; Xiaobing Yu; Linzhao Cheng; Curt I Civin; Rhonda M Alani
Journal:  J Invest Dermatol       Date:  2004-02       Impact factor: 8.551

5.  p16(Ink4a) in melanocyte senescence and differentiation.

Authors:  Elena V Sviderskaya; Simon P Hill; Tracy J Evans-Whipp; Lynda Chin; Seth J Orlow; David J Easty; Sok Ching Cheong; David Beach; Ronald A DePinho; Dorothy C Bennett
Journal:  J Natl Cancer Inst       Date:  2002-03-20       Impact factor: 13.506

6.  Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.

Authors:  Alan K Meeker; Jessica L Hicks; Elizabeth A Platz; Gerrun E March; Christina J Bennett; Michael J Delannoy; Angelo M De Marzo
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

7.  Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer.

Authors:  Sebastian F Schoppmann; Monika Schindl; Guenther Bayer; Klaus Aumayr; Julia Dienes; Reinhard Horvat; Margaretha Rudas; Michael Gnant; Raimund Jakesz; Peter Birner
Journal:  Int J Cancer       Date:  2003-05-10       Impact factor: 7.396

8.  The helix-loop-helix protein id-1 delays onset of replicative senescence in human endothelial cells.

Authors:  Jun Tang; Gabriel M Gordon; Brian J Nickoloff; Kimberly E Foreman
Journal:  Lab Invest       Date:  2002-08       Impact factor: 5.662

9.  Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors.

Authors:  Monika Schindl; Sebastian F Schoppmann; Thomas Ströbel; Harald Heinzl; Christina Leisser; Reinhard Horvat; Peter Birner
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

10.  High frequency of BRAF mutations in nevi.

Authors:  Pamela M Pollock; Ursula L Harper; Katherine S Hansen; Laura M Yudt; Mitchell Stark; Christiane M Robbins; Tracy Y Moses; Galen Hostetter; Urs Wagner; John Kakareka; Ghadi Salem; Tom Pohida; Peter Heenan; Paul Duray; Olli Kallioniemi; Nicholas K Hayward; Jeffrey M Trent; Paul S Meltzer
Journal:  Nat Genet       Date:  2002-11-25       Impact factor: 38.330

View more
  5 in total

1.  Smurf2-mediated ubiquitination and degradation of Id1 regulates p16 expression during senescence.

Authors:  Yahui Kong; Hang Cui; Hong Zhang
Journal:  Aging Cell       Date:  2011-10-07       Impact factor: 9.304

2.  Id1 overexpression is independent of repression and epigenetic silencing of tumor suppressor genes in melanoma.

Authors:  Megan A Healey; Staci L Deaton; Jonathan K Alder; Véronique Winnepenninckx; Robert A Casero; James G Herman
Journal:  Epigenetics       Date:  2010-07-01       Impact factor: 4.528

3.  Id1 promotes tumor cell migration in nonsmall cell lung cancers.

Authors:  Raka Bhattacharya; Jeanne Kowalski; Allison R Larson; Malcolm Brock; Rhoda M Alani
Journal:  J Oncol       Date:  2010-04-18       Impact factor: 4.375

Review 4.  Disruptive chemicals, senescence and immortality.

Authors:  Amancio Carnero; Carmen Blanco-Aparicio; Hiroshi Kondoh; Matilde E Lleonart; Juan Fernando Martinez-Leal; Chiara Mondello; A Ivana Scovassi; William H Bisson; Amedeo Amedei; Rabindra Roy; Jordan Woodrick; Annamaria Colacci; Monica Vaccari; Jayadev Raju; Fahd Al-Mulla; Rabeah Al-Temaimi; Hosni K Salem; Lorenzo Memeo; Stefano Forte; Neetu Singh; Roslida A Hamid; Elizabeth P Ryan; Dustin G Brown; John Pierce Wise; Sandra S Wise; Hemad Yasaei
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

5.  Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells.

Authors:  Gai Yan; Mark S Eller; Courtney Elm; Cecilia A Larocca; Byungwoo Ryu; Izabela P Panova; Beverley M Dancy; Erin M Bowers; David Meyers; Lisa Lareau; Philip A Cole; Sean D Taverna; Rhoda M Alani
Journal:  J Invest Dermatol       Date:  2013-04-18       Impact factor: 8.551

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.